51˶

Alzheimer's Tied to Military Service; Long COVID Sleepiness; NurOwn Tries Again

— News and commentary from the world of neurology and neuroscience

MedpageToday
Neuro Break over a computer rendering of neurons.

Military service was linked with at autopsy. (Alzheimer's and Dementia)

Ten hours of acoustic stimulation while resting in a zero-gravity chair . (Annals of Clinical and Translational Neurology)

Long-term effects of (ARIA) -- a side effect of Alzheimer's drugs like lecanemab (Leqembi) -- need to be reported, an NIH researcher advocated. (STAT)

Neuropsychiatric symptoms like irritability were in Alzheimer's disease. (JAMA Network Open)

Undiagnosed obstructive sleep apnea syndrome emerged as a in some long COVID patients. (European Journal of Neurology)

Small sounds contained accurate information about contemporaneous eye movements. (PNAS)

Alzheimer's disease was positively correlated with in plasma. (Alzheimer's and Dementia)

Biological sex may influence the role of amyloid-beta on tau phosphorylation and underlie in women with Alzheimer's. (Brain)

BrainStorm Cell Therapeutics said the FDA agreed to for a phase III trial of its mesenchymal stromal cells secreting neurotrophic factors therapy (NurOwn) in ALS. In September, an FDA panel overwhelmingly rejected the investigational cell therapy.

Shoulder-fired rockets expose U.S. troops to , but they remain in wide use despite known brain risks. (New York Times)

Large language models used routine clinical notes to . (Lancet Digital Health)

Scott Ramsay, PhD, a former Western Hockey League player who is now a , called for better follow-up care for kids with head injuries. (CTV News Vancouver)

Asklepios BioPharmaceutical said the first patient was randomized in its phase I trial of for multiple system atrophy-parkinsonian type.

  • Judy George covers neurology and neuroscience news for 51˶, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.